Vaccine Development Pathway

Lawrence R. Stanberry; Alan D.T. Barrett

doi:10.1016/B978-0-12-369408-9.00004-4

Vaccine Development Pathway

Lawrence R. Stanberry
, Alan D.T. Barrett

Pathology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The process to develop a vaccine becomes longer and more complex each year due to the many steps required to prepare and get a product licensed. Here, we overview the complex pathway that is needed to develop a vaccine. The process starts with basic science/discovery, proceeds through preclinical development, to clinical trials, manufacturing, registration/licensure, implementation, and finally post-marketing surveillance.

Original language	English (US)
Title of host publication	Vaccines for Biodefense and Emerging and Neglected Diseases
Publisher	Elsevier
Pages	45-54
Number of pages	10
ISBN (Electronic)	9780123694089
DOIs	https://doi.org/10.1016/B978-0-12-369408-9.00004-4
State	Published - Jan 1 2008

ASJC Scopus subject areas

General Immunology and Microbiology

Access to Document

10.1016/B978-0-12-369408-9.00004-4

Cite this

@inbook{635a3ebe4cf34ef9848a367fa09b05e3,

title = "Vaccine Development Pathway",

abstract = "The process to develop a vaccine becomes longer and more complex each year due to the many steps required to prepare and get a product licensed. Here, we overview the complex pathway that is needed to develop a vaccine. The process starts with basic science/discovery, proceeds through preclinical development, to clinical trials, manufacturing, registration/licensure, implementation, and finally post-marketing surveillance.",

author = "Stanberry, \{Lawrence R.\} and Barrett, \{Alan D.T.\}",

year = "2008",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-369408-9.00004-4",

language = "English (US)",

pages = "45--54",

booktitle = "Vaccines for Biodefense and Emerging and Neglected Diseases",

publisher = "Elsevier",

}

TY - CHAP

T1 - Vaccine Development Pathway

AU - Stanberry, Lawrence R.

AU - Barrett, Alan D.T.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - The process to develop a vaccine becomes longer and more complex each year due to the many steps required to prepare and get a product licensed. Here, we overview the complex pathway that is needed to develop a vaccine. The process starts with basic science/discovery, proceeds through preclinical development, to clinical trials, manufacturing, registration/licensure, implementation, and finally post-marketing surveillance.

AB - The process to develop a vaccine becomes longer and more complex each year due to the many steps required to prepare and get a product licensed. Here, we overview the complex pathway that is needed to develop a vaccine. The process starts with basic science/discovery, proceeds through preclinical development, to clinical trials, manufacturing, registration/licensure, implementation, and finally post-marketing surveillance.

UR - https://www.scopus.com/pages/publications/85148811886

UR - https://www.scopus.com/pages/publications/85148811886#tab=citedBy

U2 - 10.1016/B978-0-12-369408-9.00004-4

DO - 10.1016/B978-0-12-369408-9.00004-4

M3 - Chapter

AN - SCOPUS:85148811886

SP - 45

EP - 54

BT - Vaccines for Biodefense and Emerging and Neglected Diseases

PB - Elsevier

ER -

Vaccine Development Pathway

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this